कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
cobalt pharmaceuticals company - ropinirole (ropinirole hydrochloride) - tablet - 1mg - ropinirole (ropinirole hydrochloride) 1mg - nonergot-derivative dopamine receptor agonists
कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
cobalt pharmaceuticals company - ropinirole (ropinirole hydrochloride) - tablet - 2mg - ropinirole (ropinirole hydrochloride) 2mg - nonergot-derivative dopamine receptor agonists
कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
cobalt pharmaceuticals company - ropinirole (ropinirole hydrochloride) - tablet - 5mg - ropinirole (ropinirole hydrochloride) 5mg - nonergot-derivative dopamine receptor agonists
कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
sanis health inc - ropinirole (ropinirole hydrochloride) - tablet - 0.25mg - ropinirole (ropinirole hydrochloride) 0.25mg - nonergot-derivative dopamine receptor agonists
कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
sanis health inc - ropinirole (ropinirole hydrochloride) - tablet - 1mg - ropinirole (ropinirole hydrochloride) 1mg - nonergot-derivative dopamine receptor agonists
कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
sanis health inc - ropinirole (ropinirole hydrochloride) - tablet - 2mg - ropinirole (ropinirole hydrochloride) 2mg - nonergot-derivative dopamine receptor agonists
कनाडा -
अंग्रेज़ी -
Health Canada
ropinirole tablet
sanis health inc - ropinirole (ropinirole hydrochloride) - tablet - 5mg - ropinirole (ropinirole hydrochloride) 5mg - nonergot-derivative dopamine receptor agonists
संयुक्त राज्य -
अंग्रेज़ी -
NLM (National Library of Medicine)
ropinirole hydrochloride tablet film coated extended release
mylan pharmaceuticals inc. - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole 2 mg
संयुक्त राज्य -
अंग्रेज़ी -
NLM (National Library of Medicine)
ropinirole hydrochloride tablet film coated extended release
avera mckennan hospital - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole 8 mg
संयुक्त राज्य -
अंग्रेज़ी -
NLM (National Library of Medicine)
ropinirole tablet, film coated
marlex pharmaceuticals inc - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole tablets are indicated for the treatment of parkinson’s disease. ropinirole tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). ropinirole hydrochloride is contraindicated in patients known to have a hypersensitivity/allergic reaction (including urticaria, angioedema, rash, pruritus) to ropinirole or to any of the excipients. risk summary there are no adequate data on the developmental risk associated with the use of ropinirole hydrochloride in pregnant women. in animal studies, ropinirole had adverse effects on development when administered to pregnant rats at doses similar to (neurobehavioral impairment) or greater than (teratogenicity and embryolethality at >36 times) the maximum recommended human dose (mrhd) for parkinson’s disease. ropinirole doses associated with teratogenicity and embryolethality in pregnant rats were associated with maternal toxicity. in pregnant rabbits, ropinirole potentiated the teratogenic effects of l-dopa when these drugs